Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer.

Molecular & Cellular Proteomics : MCP
Xinyan WuAkhilesh Pandey

Abstract

Tamoxifen, an estrogen receptor-α (ER) antagonist, is an important agent for the treatment of breast cancer. However, this therapy is complicated by the fact that a substantial number of patients exhibit either de novo or acquired resistance. To characterize the signaling mechanisms underlying this resistance, we treated the MCF7 breast cancer cell line with tamoxifen for over six months and showed that this cell line acquired resistance to tamoxifen in vitro and in vivo. We performed SILAC-based quantitative phosphoproteomic profiling on the tamoxifen resistant and vehicle-treated sensitive cell lines to quantify the phosphorylation alterations associated with tamoxifen resistance. From >5600 unique phosphopeptides identified, 1529 peptides exhibited hyperphosphorylation and 409 peptides showed hypophosphorylation in the tamoxifen resistant cells. Gene set enrichment analysis revealed that focal adhesion pathway was one of the most enriched signaling pathways activated in tamoxifen resistant cells. Significantly, we showed that the focal adhesion kinase FAK2 was not only hyperphosphorylated but also transcriptionally up-regulated in tamoxifen resistant cells. FAK2 suppression by specific siRNA knockdown or a small molecule inh...Continue Reading

References

Jan 20, 2000·Journal of the National Cancer Institute·A BrinkmanL C Dorssers
Jan 20, 2000·Journal of the National Cancer Institute·S van der FlierJ A Foekens
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C K OsborneS A Fuqua
May 18, 2001·Nature·P Blume-Jensen, T Hunter
Oct 18, 2001·Molecular and Cellular Biology·P J RuestS K Hanks
Mar 1, 2002·British Journal of Cancer·G Pérez-TenorioUNKNOWN Southeast Sweden Breast Cancer Group
Mar 6, 2003·Journal of the National Cancer Institute·C Kent OsborneRachel Schiff
Mar 15, 2003·Nature Reviews. Cancer·Simak Ali, R Charles Coombes
May 13, 2003·The Journal of Biological Chemistry·Rebecca B RigginsAmy H Bouton
Oct 9, 2003·Breast Cancer Research and Treatment·Iain R HutchesonRobert I Nicholson
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·C Kent Osborne, Rachel Schiff
Jun 17, 2004·Journal of the National Cancer Institute·Jiang ShouRachel Schiff
Jul 13, 2004·Biochimica Et Biophysica Acta·David Chodniewicz, Richard L Klemke
Jul 27, 2004·Oncogene·Jan BrábekSteven K Hanks
Aug 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sean A BeausoleilSteven P Gygi
Dec 23, 2004·Endocrine-related Cancer·Alistair Ring, Mitch Dowsett
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Satyajit K MitraDavid D Schlaepfer
Mar 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Carolina GutierrezMitch Dowsett
Mar 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Kent Osborne, Rachel Schiff
Apr 29, 2005·Molecular & Cellular Proteomics : MCP·Martin R LarsenThomas J D Jørgensen
Aug 10, 2005·The Journal of Pathology·Tove KirkegaardJohn M S Bartlett
Jan 18, 2006·Biochemical and Biophysical Research Communications·Maricarmen D Planas-SilvaJ Stanley Smith
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beverly Moy, Paul E Goss
Nov 6, 2007·Breast Cancer Research : BCR·Alexandra F LearyStephen R D Johnston
Oct 24, 2008·International Journal of Clinical Oncology·Hiroko Yamashita
Mar 31, 2009·Molecular & Cellular Proteomics : MCP·Arzu UmarLjiljana Pasa-Tolić
Apr 24, 2009·Journal of Proteome Research·Marina SpivakWilliam Stafford Noble
Nov 4, 2010·The Journal of Biological Chemistry·Masaaki OyamaMariko Okada-Hatakeyama
Sep 23, 2011·Journal of Proteome Research·Shawna Mae HengelDavid R Goodlett
Jan 2, 2013·Cellular Signalling·Angela BarrettPaul Frankel
Jul 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kala VisvanathanScott M Lippman
May 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinJennifer J Griggs

❮ Previous
Next ❯

Citations

Mar 27, 2016·Science Signaling·Paulo Sérgio L de OliveiraDeborah Schechtman
Mar 14, 2017·Expert Opinion on Drug Discovery·Heather C MurrayNicole M Verrills
Mar 31, 2017·Cell Communication and Signaling : CCS·Wolfgang GruberChristian G Huber
Jul 3, 2019·Journal of Bacteriology·Landon J GetzNikhil A Thomas
Oct 1, 2020·The Analyst·Mustafa Gani SürmenNesrin Emekli
Jul 20, 2016·Oncology Reports·Ming WanYun-Fu Cui
Apr 18, 2017·Biomedit︠s︡inskai︠a︡ khimii︠a︡·M G ZavialovaE N Nikolaev

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.